---
title: "Jiangxi Rimag Group Co., Ltd. (02522.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/02522.HK.md"
symbol: "02522.HK"
name: "Jiangxi Rimag Group Co., Ltd."
industry: "Health Care Services"
---

# Jiangxi Rimag Group Co., Ltd. (02522.HK)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Location | HK Market |
| Website | [www.rimag.com.cn](https://www.rimag.com.cn) |

## Company Profile

Jiangxi Rimag Group Co., Ltd. invests and operates medical imaging centers in China. It operates through Imaging center Services; Imaging Solution Services; and Rimag Cloud Services segments. The company offers imaging examination and diagnostic service, such as MRI, CT, PET, X-ray, ultrasound, fluo...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:11.000Z

**Overall: C (0.58)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 5 / 28 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.28% |  |
| Net Profit YoY | -732.82% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.69 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.95B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 882.60M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -2.14% | D |
| Profit Margin | -4.09% | D |
| Gross Margin | 29.39% | C |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.28% | C |
| Net Profit YoY | -732.82% | E |
| Total Assets YoY | 13.31% | B |
| Net Assets YoY | 5.94% | B |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -2443.34% | E |
| OCF YoY | 0.28% | C |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.35 | C |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 32.93% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Jiangxi Rimag Group Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-2.14%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-4.09%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "29.39%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.28%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-732.82%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "13.31%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "5.94%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-2443.34%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "0.28%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.35",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "32.93%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | GUSHENGTANG (HK.2273) | B | B | B | B | B | B |
| 02 | HUMAN HEALTH (HK.1419) | C | C | B | B | B | B |
| 03 | UNI MEDICAL (HK.2666) | B | C | D | D | B | C |
| 04 | HEALTHYWAY INC (HK.2587) | B | C | A | D | E | C |
| 05 | RIMAG GROUP (HK.2522) | D | C | C | B | D | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -80.63 | 28/29 | 2778.87 | 2091.09 | 1508.18 |
| PB | 1.69 | 15/29 | 4.56 | 3.70 | 2.27 |
| PS (TTM) | 3.30 | 25/29 | 8.68 | 7.19 | 4.45 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-16T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 7.45 |
| Highest Target | 35.72 |
| Lowest Target | 35.72 |

## References

- [Company Overview](https://longbridge.com/en/quote/02522.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/02522.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/02522.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.